Medtronic Takes Next Step As Heart-Failure Service Provider
This article was originally published in The Gray Sheet
The firm signaled its plan three years ago to transform itself into more of a services partner for hospitals than a product supplier. It took the latest step in that direction with the launch of service for heart-failure management, combing data from its cardiac rhythm management devices and its remote-monitoring offerings.
You may also be interested in...
The deal gives Medtronic its first ventricular-assist devices and gives struggling HeartWare a needed boost.
Medtronic hopes the $200 million purchase of telehealth firm Cardiocom will enhance its ability to respond to increasing demands on hospitals to better manage patient outcomes and costs. It will also greatly expand its customer base.
News We're Watching: GE, Biofourmis Partnership, Tricuspid Procedure Boom, Boston Scientific Borrows $2Bn, And More
Medtech Insight's News We're Watching highlights some recent business and R&D developments you may have missed. This week, GE Healthcare and Biofourmis announced a deal to collaborate on virtual care; Cleerly touts a new CPT code for its Ischemia cardiac diagnostic software; Boston Scientific announced how it plans to pay for Axonics; a Wells Fargo survey suggests the market for transcatheter tricuspid valve repair and replacement will grow faster than previously imagined; Virtual Incision earns FDA de novo authorization for its MIRA miniaturized surgical system for colectomy procedures; and MMI and Fabric announce major financing rounds.